Post-earnings recap
Reported
Thu, Jan 30, 2025
EPS actual
$2.43
EPS est.
$2.30
EPS surprise
+5.56%
1-day move
+1.89%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
ResMed's earnings report shows a solid EPS performance, which contributed to a positive stock reaction, rising 1.89%. The company did not provide revenue figures or future guidance, leaving investors to focus on the EPS beat as a sign of strength. Management's comments suggest a focus on innovation and customer satisfaction moving forward.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.43 | N/A | +5.56% |
| Revenue | N/A | N/A | N/A |
Management expressed satisfaction with the earnings performance, particularly the EPS beat. They emphasized ongoing commitment to innovation.
We are pleased with our EPS performance this quarter.
Our focus remains on innovation and meeting customer needs.